Skip to main content
Log in

Newly observed thalamic involvement and mutations of the HEXA gene in a Korean patient with juvenile GM2 gangliosidosis

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Neuroimaging studies of patients with GM2 gangliosidosis are rare. The thalamus and basal ganglia are principally involved in patients affected by the infantile form of GM2 gangliosidosis. Unlike in the infantile form, in juvenile or adult type GM2 gangliosidosis, progressive cortical and cerebellar atrophy is the main abnormality seen on conventional magnetic resonance imaging (MRI); no basal ganglial or thalamic impairment were observed. This report is of a Korean girl with subacute onset, severe deficiency of hexosaminidase A activity and mutations (Arg137Term, Ala246Thr) of the HEXA gene. A 3.5-year-old girl who was previously in good health was evaluated for hypotonia and ataxia 3 months ago and showed progressive developmental deterioration, including cognitive decline. Serial brain MRI showed progressive overall volume decrease of the entire brain and thalamic atrophy. Fluorine-18 FDG PET scan showed severe decreased uptake in bilateral thalamus and diffuse cerebral cortex. We suggest, through our experience, that the thalamic involvement in MR imaging and FDG-PET can be observed in the juvenile form of GM2 gangliosidosis, and we suspect the association of mutations in the HEXA gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A (1991) Seven novel mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11:124–134

    Article  PubMed  CAS  Google Scholar 

  • Beck M, Sieber N, Goebel HH (1998) Progressive cerebellar ataxia in juvenile GM2-gangliosidosis type Sandhoff. Eur J Pediatr 157(10):866–867

    Article  PubMed  CAS  Google Scholar 

  • Conzelmann E, Kytzia HJ, Navon R, Sandhoff K (1983) Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet 35(5):900–913

    PubMed  CAS  Google Scholar 

  • Fernandes Filho JA, Shapiro BE (2004) Tay–Sachs disease. Arch Neurol 61(9):1466–1468

    Article  PubMed  Google Scholar 

  • Frey LC, Ringel SP, Filley CM (2005) The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. Arch Neurol 62(6):989–994 Jun

    Article  PubMed  Google Scholar 

  • Fukumizu M, Yoshikawa H, Takashima S, Sakuragawa N, Kurokawa T (1992) Tay–Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 34(6):483–486

    Article  PubMed  CAS  Google Scholar 

  • Gravel R, Kaback M, Proia R, Sandhoff K, Suzuki K (2001) The GM2 gangliosidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. 8th edn. McGraw-Hill, New York, NY, pp 3827–3876

    Google Scholar 

  • Grosso S, Farnetani MA, Berardi R, Margollicci M, Galluzzi P, Vivarelli R, Morgese G, Ballestri P (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250(1):17–21

    Article  PubMed  Google Scholar 

  • Hund E, Grau A, Fogel W, Forsting M, Cantz M, Kustermann-Kuhn B, Harzer K, Navon R, Goebel HH, Meinck HM (1997) Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 145(1):25–31

    Article  PubMed  CAS  Google Scholar 

  • Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O (2005) MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. Am J Neuroradiol 26(8):2037–2042

    PubMed  Google Scholar 

  • Kaback MM (2000) Population-based genetic screening for reproductive counseling: the Tay–Sachs disease model. Eur J Pediatr 159(Suppl 3):S192–S195

    Article  PubMed  CAS  Google Scholar 

  • Kaback MM, Zeiger RS, Reynolds LW, Sonneborn M (1974) Approaches to the control and prevention of Tay–Sachs disease. Prog Med Genet 10:103–134

    PubMed  CAS  Google Scholar 

  • Kamatani N, Hakoda M, Otsuka S, Yoshikawa H, Kashiwazaki S (1992) Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J Clin Invest 90(1):130–135

    Article  PubMed  CAS  Google Scholar 

  • Maegawa GH, Stockley T, Tropak M, Banwell B, Blaser S, Kok F, Giugliani R, Mahuran D, Clarke JT (2006) The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 118(5):e1550–e1562 Epub 2006 Oct 2

    Article  PubMed  Google Scholar 

  • Montalvo AL, Filocamo M, Vlahovicek K, Dardis A, Lualdi S, Corsolini F, Bembi B, Pittis MG (2005) Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay–Sachs disease: detection of fourteen novel alleles. Human Mutat 26(3):1–9

    Article  Google Scholar 

  • Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K (1996) MR findings in Tay–Sachs disease. J Comput Assist Tomogr 20(4):551–555

    Article  PubMed  CAS  Google Scholar 

  • Myerowitz R, Costigan FC (1988) The major defect in Ashkenazi Jews with Tay–Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. J Biol Chem 263(35):18587–18589

    PubMed  CAS  Google Scholar 

  • Neudorfer O, Pastores GM, Zeng BJ, Gianutsos J, Zaroff CM, Kolodny EH (2005) Late-onset Tay–Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med 7(2):119–123

    Article  PubMed  CAS  Google Scholar 

  • Ozkara HA, Navon R (1998) At least six different mutations in HEXA gene cause Tay–Sachs disease among the Turkish population. Mol Genet Metab 65(3):250–253

    Article  PubMed  CAS  Google Scholar 

  • Paw BH, Kaback MM, Neufeld EF (1989) Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. Proc Natl Acad Sci USA 86(7):2413–2417 (Erratum in: Proc Natl Acad Sci USA 86(14):5625)

    Article  PubMed  CAS  Google Scholar 

  • Specola N, Vanier MT, Goutieres F, Mikol J, Aicardi J (1990) The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. Neurology 40(1):145–150

    PubMed  CAS  Google Scholar 

  • Streifler JY, Gornish M, Hadar H, Gadoth N (1993) Brain imaging in late-onset GM2 gangliosidosis. Neurology 43(10):2055–2058

    PubMed  CAS  Google Scholar 

  • Sutton VR (2002) Tay–Sachs disease screening and counseling families at risk for metabolic disease. Obstet Gynecol Clin North Am 29(2):287–296

    Article  PubMed  Google Scholar 

  • Triggs-Raine BL, Feigenbaum AS, Natowicz M, Skomorowski MA, Schuster SM, Clarke JT, Mahuran DJ, Kolodny EH, Gravel RA (1990) Screening for carriers of Tay–Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med 323(1):6–12

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

There are no conflicts of interest among authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Mock Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S.M., Lee, M.J., Lee, J.S. et al. Newly observed thalamic involvement and mutations of the HEXA gene in a Korean patient with juvenile GM2 gangliosidosis. Metab Brain Dis 23, 235–242 (2008). https://doi.org/10.1007/s11011-008-9090-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9090-9

Keywords

Navigation